file1,
file2, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*).
Wildcard '?' to blanket only one character works too.| Historiographs |
Grand Totals: LCS 7398, GCS 21737, CR 38784 Collection span: 1977 - 2012 | |
| Word(i) List (2518) Word count: 12056, All words count: 16977 | ||
| # | Word | Recs | TLCS | TGCS |
|---|---|---|---|---|
| 2001 | UNLIKELY | 1 | 0 | 2 |
| 2002 | USEFULNESS | 1 | 2 | 2 |
| 2003 | VITILIGO | 1 | 1 | 2 |
| 2004 | Y-CHROMOSOME-SPECIFIC | 1 | 2 | 2 |
| 2005 | ACCELERATED | 2 | 0 | 1 |
| 2006 | ADMINISTERED | 1 | 1 | 1 |
| 2007 | AMPLIFY | 1 | 0 | 1 |
| 2008 | ANALYSIS-OF | 1 | 0 | 1 |
| 2009 | ANTIADHESION | 1 | 0 | 1 |
| 2010 | ANTIGEN-MATCHED | 1 | 1 | 1 |
| 2011 | APLASIA | 1 | 0 | 1 |
| 2012 | BASIC | 1 | 1 | 1 |
| 2013 | BENEVOLENCE | 1 | 1 | 1 |
| 2014 | BUTTON | 1 | 0 | 1 |
| 2015 | CAPACITY | 1 | 1 | 1 |
| 2016 | CHROMOSOME-POSITIVE | 1 | 0 | 1 |
| 2017 | CLONE | 1 | 0 | 1 |
| 2018 | COLONIZATION | 2 | 0 | 1 |
| 2019 | COMPARED | 1 | 0 | 1 |
| 2020 | COMPETENT | 1 | 1 | 1 |
| 2021 | CONCENTRATES | 1 | 1 | 1 |
| 2022 | CONCISE | 1 | 0 | 1 |
| 2023 | CONSISTENT | 1 | 1 | 1 |
| 2024 | CONTENT | 1 | 1 | 1 |
| 2025 | CTL | 1 | 0 | 1 |
| 2026 | CYTOGENETIC | 1 | 0 | 1 |
| 2027 | DERIVE | 1 | 0 | 1 |
| 2028 | DERMATOSES | 1 | 0 | 1 |
| 2029 | DETECTED | 1 | 1 | 1 |
| 2030 | DEVELOPED | 1 | 0 | 1 |
| # | Word | Recs | TLCS | TGCS |
| 2031 | DIFFERENTIAL | 1 | 0 | 1 |
| 2032 | DIFFERENTIATE | 1 | 1 | 1 |
| 2033 | DILEMMAS | 1 | 0 | 1 |
| 2034 | DISPERMIC | 1 | 0 | 1 |
| 2035 | DOUBLE | 1 | 0 | 1 |
| 2036 | DQA | 1 | 1 | 1 |
| 2037 | DYNAMICS | 1 | 0 | 1 |
| 2038 | EDITOR | 1 | 0 | 1 |
| 2039 | ERYTHEMA | 1 | 0 | 1 |
| 2040 | ETIOPATHOGENETIC | 1 | 0 | 1 |
| 2041 | FAVOURABLE | 1 | 1 | 1 |
| 2042 | FEARS | 1 | 1 | 1 |
| 2043 | FINDING | 1 | 1 | 1 |
| 2044 | FOLLOW | 1 | 0 | 1 |
| 2045 | GESTATIONIS | 1 | 0 | 1 |
| 2046 | GLOMERULAR | 1 | 1 | 1 |
| 2047 | GRAFT-VERSUS-LEUKEMIA | 1 | 0 | 1 |
| 2048 | HITTING | 1 | 0 | 1 |
| 2049 | HLA-DQA | 1 | 1 | 1 |
| 2050 | HOPES | 1 | 1 | 1 |
| 2051 | HSCT | 1 | 0 | 1 |
| 2052 | IDENTIFIED | 2 | 0 | 1 |
| 2053 | IL-4 | 1 | 0 | 1 |
| 2054 | INFLUENCES | 2 | 0 | 1 |
| 2055 | INJECTIONS | 1 | 0 | 1 |
| 2056 | INSIGHT | 1 | 1 | 1 |
| 2057 | INSULIN-EXPRESSING | 1 | 0 | 1 |
| 2058 | INTRA-UTERINE | 1 | 0 | 1 |
| 2059 | ISOLATE | 1 | 0 | 1 |
| 2060 | ISOTHERMAL | 1 | 0 | 1 |
| # | Word | Recs | TLCS | TGCS |
| 2061 | JAPANESE-BRAZILIANS | 1 | 0 | 1 |
| 2062 | LA-IDENTICAL | 1 | 1 | 1 |
| 2063 | LATER | 2 | 1 | 1 |
| 2064 | LETHAL | 1 | 0 | 1 |
| 2065 | LETTERS | 1 | 0 | 1 |
| 2066 | LIGAND-TREATED | 1 | 0 | 1 |
| 2067 | LITTERMATES | 1 | 1 | 1 |
| 2068 | LIVE | 1 | 0 | 1 |
| 2069 | LIVER-TRANSPLANTED | 1 | 1 | 1 |
| 2070 | LOTUS | 1 | 0 | 1 |
| 2071 | LOWER | 3 | 1 | 1 |
| 2072 | MALEVOLENCE | 1 | 1 | 1 |
| 2073 | MANIPULATION | 1 | 0 | 1 |
| 2074 | MCMV | 2 | 0 | 1 |
| 2075 | MDS | 1 | 0 | 1 |
| 2076 | MEDIATES | 2 | 0 | 1 |
| 2077 | MEDICAL | 2 | 1 | 1 |
| 2078 | MEDICATION | 3 | 0 | 1 |
| 2079 | MEDICINE | 1 | 1 | 1 |
| 2080 | METHODS | 2 | 1 | 1 |
| 2081 | MISSED | 1 | 0 | 1 |
| 2082 | MOLECULAR-BIOLOGICAL | 1 | 1 | 1 |
| 2083 | MRNA | 1 | 0 | 1 |
| 2084 | MYOCARDIUM | 1 | 1 | 1 |
| 2085 | MYOFIBROMATOSIS | 1 | 0 | 1 |
| 2086 | MYOSITIS | 1 | 1 | 1 |
| 2087 | MYOSITIS-SPECIFIC | 1 | 0 | 1 |
| 2088 | NEON | 1 | 0 | 1 |
| 2089 | NEURONS | 1 | 1 | 1 |
| 2090 | NODULES | 2 | 0 | 1 |
| # | Word | Recs | TLCS | TGCS |
| 2091 | NON-DC | 1 | 0 | 1 |
| 2092 | NON-PARENCHYMAL | 1 | 0 | 1 |
| 2093 | NULLIGRAVID | 2 | 1 | 1 |
| 2094 | OPPORTUNITIES | 1 | 0 | 1 |
| 2095 | OVERT | 1 | 0 | 1 |
| 2096 | OVERVIEW | 1 | 0 | 1 |
| 2097 | PARENTAL | 1 | 0 | 1 |
| 2098 | PARTICIPATING | 1 | 0 | 1 |
| 2099 | PEMPHIGOID | 1 | 0 | 1 |
| 2100 | PERIOPERATIVELY | 1 | 1 | 1 |
| 2101 | PHILADELPHIA | 1 | 0 | 1 |
| 2102 | PRE-TRANSPLANT | 2 | 0 | 1 |
| 2103 | PREDICTION | 1 | 1 | 1 |
| 2104 | PREDOMINANT | 1 | 0 | 1 |
| 2105 | PRESENTING | 1 | 1 | 1 |
| 2106 | PROGRESSION | 1 | 1 | 1 |
| 2107 | PROLONGATION | 1 | 1 | 1 |
| 2108 | PROLONGS | 1 | 0 | 1 |
| 2109 | PROVES | 1 | 0 | 1 |
| 2110 | REALTIME | 2 | 0 | 1 |
| 2111 | REFLECTS | 1 | 0 | 1 |
| 2112 | REJECTING | 1 | 0 | 1 |
| 2113 | RELEASED | 1 | 0 | 1 |
| 2114 | RESCUED | 1 | 0 | 1 |
| 2115 | RESET | 1 | 0 | 1 |
| 2116 | RESP | 1 | 0 | 1 |
| 2117 | REVERTED | 1 | 0 | 1 |
| 2118 | RITUXIMAB | 1 | 0 | 1 |
| 2119 | SELECTING | 1 | 0 | 1 |
| 2120 | SELECTIVELY | 1 | 0 | 1 |
| # | Word | Recs | TLCS | TGCS |
| 2121 | SEMI-QUANTITATIVE | 1 | 0 | 1 |
| 2122 | SENESCENCE | 1 | 0 | 1 |
| 2123 | SEPARATE | 1 | 0 | 1 |
| 2124 | SERVICES | 1 | 0 | 1 |
| 2125 | SICKLE | 3 | 1 | 1 |
| 2126 | SIMULATENOUSLY | 1 | 1 | 1 |
| 2127 | SPLENOCYTE | 1 | 0 | 1 |
| 2128 | SSC | 1 | 1 | 1 |
| 2129 | SURVIVORS | 2 | 1 | 1 |
| 2130 | TEMPORAL | 1 | 1 | 1 |
| 2131 | TEN | 1 | 1 | 1 |
| 2132 | TH2 | 1 | 0 | 1 |
| 2133 | THIRTY | 1 | 1 | 1 |
| 2134 | TOLL-LIKE | 1 | 0 | 1 |
| 2135 | TOX | 1 | 0 | 1 |
| 2136 | TYROSINEMIA | 1 | 0 | 1 |
| 2137 | ULCERS | 1 | 1 | 1 |
| 2138 | UNDER-RECOGNIZED | 1 | 1 | 1 |
| 2139 | UPDATE | 2 | 0 | 1 |
| 2140 | VALIDATION | 1 | 0 | 1 |
| 2141 | VARIATION | 1 | 1 | 1 |
| 2142 | VEIN | 1 | 1 | 1 |
| 2143 | VERTEBRAE | 1 | 0 | 1 |
| 2144 | VIABLE | 2 | 0 | 1 |
| 2145 | VNTR | 1 | 0 | 1 |
| 2146 | WHOLE-GENOME | 1 | 0 | 1 |
| 2147 | YOUNG | 1 | 0 | 1 |
| 2148 | YOUNGER | 1 | 1 | 1 |
| 2149 | 12-YEAR-OLD | 1 | 0 | 0 |
| 2150 | ACCURATE | 1 | 0 | 0 |
| # | Word | Recs | TLCS | TGCS |
| 2151 | ACTIVATE | 1 | 0 | 0 |
| 2152 | ADAPTIVE | 1 | 0 | 0 |
| 2153 | ADDITIONAL | 1 | 0 | 0 |
| 2154 | ADENOIDS | 1 | 0 | 0 |
| 2155 | ADVANTAGE | 1 | 0 | 0 |
| 2156 | AEGAGRUS | 1 | 0 | 0 |
| 2157 | AFFECT | 1 | 0 | 0 |
| 2158 | AFFORDS | 1 | 0 | 0 |
| 2159 | ALLERGEN | 1 | 0 | 0 |
| 2160 | ALLO | 1 | 0 | 0 |
| 2161 | ALLO-TRANSPLANTATIONS | 1 | 0 | 0 |
| 2162 | ALLOANTIGEN-PRIMED | 1 | 0 | 0 |
| 2163 | ALLOGRAFTING | 1 | 0 | 0 |
| 2164 | ALPHA-1-ANTITRYPSIN | 1 | 0 | 0 |
| 2165 | ALVEOLAR | 1 | 0 | 0 |
| 2166 | AMELIORATE | 1 | 0 | 0 |
| 2167 | AML | 2 | 0 | 0 |
| 2168 | AND-DQB1 | 3 | 0 | 0 |
| 2169 | ANTI | 2 | 0 | 0 |
| 2170 | ANTI-ADHESION | 1 | 0 | 0 |
| 2171 | ANTI-INFLAMMATORY | 1 | 0 | 0 |
| 2172 | ANTI-RLA | 1 | 0 | 0 |
| 2173 | ANTICANCER | 1 | 0 | 0 |
| 2174 | ANTIGEN-HAPLOIDENTICAL | 1 | 0 | 0 |
| 2175 | ANTITHYROID | 1 | 0 | 0 |
| 2176 | ARMS-QPCR | 1 | 0 | 0 |
| 2177 | ARTLETT | 1 | 0 | 0 |
| 2178 | ASSESS | 1 | 0 | 0 |
| 2179 | ATTEMPTED | 1 | 0 | 0 |
| 2180 | AUTO-IMMUNE | 1 | 0 | 0 |
| # | Word | Recs | TLCS | TGCS |
| 2181 | AVIDITY | 1 | 0 | 0 |
| 2182 | AWAITING | 2 | 0 | 0 |
| 2183 | BACKGROUND | 1 | 0 | 0 |
| 2184 | BARR | 1 | 0 | 0 |
| 2185 | BENEFIT | 1 | 0 | 0 |
| 2186 | BIOLOGICS | 1 | 0 | 0 |
| 2187 | BIOLOGY | 2 | 0 | 0 |
| 2188 | BLOOD-AND | 1 | 0 | 0 |
| 2189 | BLOOD-PLACENTAL | 1 | 0 | 0 |
| 2190 | BLURRING | 1 | 0 | 0 |
| 2191 | BOOST | 1 | 0 | 0 |
| 2192 | BORDERS | 1 | 0 | 0 |
| 2193 | CAPRA | 1 | 0 | 0 |
| 2194 | CAUSATION | 1 | 0 | 0 |
| 2195 | CAUSED | 2 | 0 | 0 |
| 2196 | CCL3 | 1 | 0 | 0 |
| 2197 | CD34-SELECTED | 1 | 0 | 0 |
| 2198 | CELLULITIS | 1 | 0 | 0 |
| 2199 | CHARACTERISTICS | 1 | 0 | 0 |
| 2200 | CHEMICALLY | 1 | 0 | 0 |